Long-Term Outcome of Laparoscopic Surgery for Pancreatic Neuroendocrine Tumors
Corresponding Author
Sven-Petter Haugvik
Department of Hepato-Pancreato-Biliary Surgery, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway
[email protected]Search for more papers by this authorIrina Pavlik Marangos
Interventional Centre, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
Search for more papers by this authorBård Ingvald Røsok
Department of Hepato-Pancreato-Biliary Surgery, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
Search for more papers by this authorEwa Pomianowska
Department of Hepato-Pancreato-Biliary Surgery, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway
Search for more papers by this authorIvar Prydz Gladhaug
Department of Hepato-Pancreato-Biliary Surgery, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway
Search for more papers by this authorØystein Mathisen
Department of Hepato-Pancreato-Biliary Surgery, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
Search for more papers by this authorBjørn Edwin
Department of Hepato-Pancreato-Biliary Surgery, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway
Interventional Centre, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
Search for more papers by this authorCorresponding Author
Sven-Petter Haugvik
Department of Hepato-Pancreato-Biliary Surgery, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway
[email protected]Search for more papers by this authorIrina Pavlik Marangos
Interventional Centre, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
Search for more papers by this authorBård Ingvald Røsok
Department of Hepato-Pancreato-Biliary Surgery, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
Search for more papers by this authorEwa Pomianowska
Department of Hepato-Pancreato-Biliary Surgery, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway
Search for more papers by this authorIvar Prydz Gladhaug
Department of Hepato-Pancreato-Biliary Surgery, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway
Search for more papers by this authorØystein Mathisen
Department of Hepato-Pancreato-Biliary Surgery, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
Search for more papers by this authorBjørn Edwin
Department of Hepato-Pancreato-Biliary Surgery, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway
Interventional Centre, Rikshospitalet, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway
Search for more papers by this authorAbstract
Background
As most pancreatic neuroendocrine tumors (PNET) are relatively small and solitary, they may be considered well suited for removal by a minimally invasive approach. There are few large series that describe laparoscopic surgery for PNET. The primary aim of this study was to describe the feasibility, outcome, and histopathology associated with laparoscopic pancreatic surgery (LS) of PNET in a large series.
Methods
All patients with PNET who underwent LS at a single hospital from March 1997 to April 2011 were included retrospectively in the study.
Results
A total of 72 patients with PNET underwent 75 laparoscopic procedures, out of which 65 were laparoscopic resections or enucleations. The median operative time of all patients who underwent resections or enucleations was 175 (60–520) min, the median blood loss was 300 (5–2,700) ml, and the median length of hospital stay was 7 (2–27) days. The overall morbidity rate was 42 %, with a surgical morbidity rate of 21 % and postoperative pancreatic fistula (POPF) formation in 21 %. Laparoscopic enucleations were associated with a higher rate of POPF than were laparoscopic resections. Five-year disease-specific survival rate was 90 %. The T stage, R stage, and a Ki-67 cutoff value of 5 % significantly predicted 5-year survival.
Conclusion
LS of PNET is feasible with acceptable morbidity and a good overall disease-specific long-term prognosis.
References
- 1FendrichV, BartschDK Surgical treatment of gastrointestinal neuroendocrine tumors. Langenbecks Arch Surg (2011) 396(3): 299–3112127982110.1007/s00423-011-0741-7
- 2YaoJC, HassanM, PhanA, DagohoyC, LearyC, MaresJE, AbdallaEK, FlemingJB, VautheyJN, RashidA, EvansDB One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol (2008) 26(18): 3063–30721856589410.1200/JCO.2007.15.4377
- 3HausoO, GustafssonBI, KiddM, WaldumHL, DrozdovI, ChanAK, ModlinIM Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer (2008) 113(10): 2655–26641885341610.1002/cncr.23883
- 4KimuraW, KurodaA, MoriokaY Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci (1991) 36(7): 933–942207070710.1007/BF01297144
- 5HalfdanarsonTR, RabeKG, RubinJ, PetersenGM Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol (2008) 19(10): 1727–17331851579510.1093/annonc/mdn351
- 6GagnerM, PompA, HerreraMF Early experience with laparoscopic resections of islet cell tumors. Surgery (1996) 120(6): 1051–1054895749410.1016/S0039-6060(96)80054-7
- 7RosokBI, MarangosIP, KazaryanAM, RosselandAR, BuanesT, MathisenO, EdwinB Single-centre experience of laparoscopic pancreatic surgery. Br J Surg (2010) 97(6): 902–9092047400010.1002/bjs.7020
- 8EdwinB, MalaT, MathisenO, GladhaugI, BuanesT, LundeOC, SoreideO, BerganA, FosseE Laparoscopic resection of the pancreas: a feasibility study of the short-term outcome. Surg Endosc (2004) 18(3): 407–4111475262810.1007/s00464-003-9007-y
- 9CroceE, OlmiS, BertoliniA, MagnoneS Laparoscopic surgery of pancreatic cancer: state of the art. Hepatogastroenterology (2005) 52(66): 1889–189416334801
- 10FabreJM, DulucqJL, VacherC, LemoineMC, WintringerP, NoccaD, BurgelJS, DomergueJ Is laparoscopic left pancreatic resection justified?. Surg Endosc (2002) 16(9): 1358–13611198467210.1007/s00464-001-9206-3
- 11KoobyDA Laparoscopic pancreatic resection for cancer. Expert Rev Anticancer Ther (2008) 8(10): 1597–16091892585210.1586/14737140.8.10.1597
- 12MabrutJY, Fernandez-CruzL, AzagraJS, BassiC, DelvauxG, WeertsJ, FabreJM, BoulezJ, BaulieuxJ, PeixJL, GigotJF Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients. Surgery (2005) 137(6): 597–6051596240110.1016/j.surg.2005.02.002
- 13Fernandez-CruzL, CosaR, BlancoL, LeviS, Lopez-BoadoMA, NavarroS Curative laparoscopic resection for pancreatic neoplasms: a critical analysis from a single institution. J Gastrointest Surg (2007) 11(12): 1607–16211789616710.1007/s11605-007-0266-0
- 14EomBW, JangJY, LeeSE, HanHS, YoonYS, KimSW Clinical outcomes compared between laparoscopic and open distal pancreatectomy. Surg Endosc (2008) 22(5): 1334–13381802703510.1007/s00464-007-9660-7
- 15PericleousS, MiddletonN, McKaySC, BowersKA, HutchinsRR Systematic review and meta-analysis of case-matched studies comparing open and laparoscopic distal pancreatectomy: is it a safe procedure?. Pancreas (2012) 41(7): 993–10002283685810.1097/MPA.0b013e31824f3669
- 16DiNorciaJ, SchropeBA, LeeMK, ReaveyPL, RosenSJ, LeeJA, ChabotJA, AllendorfJD Laparoscopic distal pancreatectomy offers shorter hospital stays with fewer complications. J Gastrointest Surg (2010) 14(11): 1804–18122058944610.1007/s11605-010-1264-1
- 17KoobyDA, HawkinsWG, SchmidtCM, WeberSM, BentremDJ, GillespieTW, SellersJB, MerchantNB, ScogginsCR, MartinRCIII, KimHJ, AhmadS, ChoCS, ParikhAA, ChuCK, HamiltonNA, DoyleCJ, PinchotS, HaymanA, McClaineR, NakeebA, StaleyCA, McMastersKM, LillemoeKD A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate?. J Am Coll Surg (2010) 210(5): 779–7872042104910.1016/j.jamcollsurg.2009.12.033
- 18DedieuA, RaultA, ColletD, MassonB, SaCA Laparoscopic enucleation of pancreatic neoplasm. Surg Endosc (2011) 25(2): 572–5762062323510.1007/s00464-010-1223-7
- 19DiNorciaJ, LeeMK, ReaveyPL, GenkingerJM, LeeJA, SchropeBA, ChabotJA, AllendorfJD One hundred thirty resections for pancreatic neuroendocrine tumor: evaluating the impact of minimally invasive and parenchyma-sparing techniques. J Gastrointest Surg (2010) 14(10): 1536–15462082437810.1007/s11605-010-1319-3
- 20Fernandez-CruzL, BlancoL, CosaR, RendonH Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?. World J Surg (2008) 32(5): 904–9171826482410.1007/s00268-008-9467-2
- 21PorembkaMR, HallBL, HirbeM, StrasbergSM Quantitative weighting of postoperative complications based on the accordion severity grading system: demonstration of potential impact using the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg (2010) 210(3): 286–2982019389110.1016/j.jamcollsurg.2009.12.004
- 22AnderssonR, Andrén-SandbergA, LundstedtC, TranbergKG Implantation metastases from gastrointestinal cancer after percutaneous puncture or biliary drainage. Eur J Surg (1996) 162(7): 551–5548874162
- 23PavlikMI, RosokBI, KazaryanAM, RosselandAR, EdwinB Effect of TachoSil Patch in prevention of postoperative pancreatic fistula. J Gastrointest Surg (2011) 15(9): 1625–162910.1007/s11605-011-1584-9
- 24BassiC, DervenisC, ButturiniG, FingerhutA, YeoC, IzbickiJ, NeoptolemosJ, SarrM, TraversoW, BuchlerM Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery (2005) 138(1): 8–131600330910.1016/j.surg.2005.05.001
- 25Bosman FT, Carneiro F, Hruban RH (2010) WHO classification of tumours of the digestive system. International Agency for Research on Cancer (IARC), Lyon
- 26RindiG, KloppelG, AlhmanH, CaplinM, CouvelardA, de HerderWW, EriksssonB, FalchettiA, FalconiM, KomminothP, KornerM, LopesJM, McNicolAM, NilssonO, PerrenA, ScarpaA, ScoazecJY, WiedenmannB TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2006) 449(4): 395–4011696726710.1007/s00428-006-0250-1
- 27CrippaS, BassiC, SalviaR, FalconiM, ButturiniG, PederzoliP Enucleation of pancreatic neoplasms. Br J Surg (2007) 94(10): 1254–12591758389210.1002/bjs.5833
- 28KielyJM, NakeebA, KomorowskiRA, WilsonSD, PittHA Cystic pancreatic neoplasms: enucleate or resect?. J Gastrointest Surg (2003) 7(7): 890–8971459266310.1007/s11605-003-0035-7
- 29TalaminiMA, MoesingerR, YeoCJ, PouloseB, HrubanRH, CameronJL, PittHA Cystadenomas of the pancreas: is enucleation an adequate operation?. Ann Surg (1998) 227(6): 896–903963755310.1097/00000658-199806000-00013
- 30SauvanetA Functional results of pancreatic surgery. Rev Prat (2002) 52(14): 1572–157512412306
- 31GruessnerRW, KendallDM, DrangstveitMB, GruessnerAC, SutherlandDE Simultaneous pancreas-kidney transplantation from live donors. Ann Surg (1997) 226(4): 471–480935171510.1097/00000658-199710000-00008
- 32FendrichV, MerzMK, WaldmannJ, LangerP, HeverhagenAE, DietzelK, BartschDK Neuroendocrine pancreatic tumors are risk factors for pancreatic fistula after pancreatic surgery. Dig Surg (2011) 28(4): 263–2692172016410.1159/000328667
- 33FalconiM, BartschDK, ErikssonB, KloppelG, LopesJM, O’ConnorJM, SalazarR, TaalBG, VulliermeMP, O’TooleD ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology (2012) 95(2): 120–1342226187210.1159/000335587
- 34FalconiM, PlockingerU, KwekkeboomDJ, ManfrediR, KornerM, KvolsL, PapeUF, RickeJ, GoretzkiPE, WildiS, SteinmullerT, ObergK, ScoazecJY Well-differentiated pancreatic nonfunctioning tumors/carcinoma. Neuroendocrinology (2006) 84(3): 196–2111731238010.1159/000098012
- 35NortonJA, KivlenM, LiM, SchneiderD, ChuterT, JensenRT Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch Surg (2003) 138(8): 859–8661291274410.1001/archsurg.138.8.859
- 36BruzoniM, ParikhP, CelisR, AreC, LyQP, MezaJL, SassonAR Management of the primary tumor in patients with metastatic pancreatic neuroendocrine tumor: a contemporary single-institution review. Am J Surg (2009) 197(3): 376–3811924591810.1016/j.amjsurg.2008.11.005
- 37AdsayNV, BasturkO, AltinelD, KhananiF, CobanI, WeaverDW, KoobyDA, SarmientoJM, StaleyC The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment. Mod Pathol (2009) 22(1): 107–1121882066310.1038/modpathol.2008.167
- 38PomianowskaE, GladhaugIP, GrzybK, RosokBI, EdwinB, BergestuenDS, MathisenO Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems. Scand J Gastroenterol (2010) 45(7–8): 971–9792044153010.3109/00365521003782363
- 39PhanGQ, YeoCJ, HrubanRH, LillemoeKD, PittHA, CameronJL Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg (1998) 2(5): 472–482984360810.1016/S1091-255X(98)80039-5
- 40BoninsegnaL, PanzutoF, PartelliS, CapelliP, FaveGD, BettiniR, PederzoliP, ScarpaA, FalconiM Malignant pancreatic neuroendocrine tumour: Lymph node ratio and Ki67 are predictors of recurrence after curative resections. Eur J Cancer (2012) 48(11): 1608–16152212988910.1016/j.ejca.2011.10.030